entresto
novartis europharm limited - sacubitril, valsartan - hjertefeil - angiotensin ii antagonister, andre kombinasjoner, agenter som handler på renin-angiotensin-systemet - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.
neparvis
novartis europharm limited - sacubitril, valsartan - hjertefeil - agenter som virker på renin-angiotensinsystemet - paediatric heart failureneparvis is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction (see section 5. adult heart failureneparvis is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction (see section 5.
verquvo
bayer ag - vericiguat - hjertefeil - hjertetapi - treatment of symptomatic chronic heart failure.
entresto 24 mg / 26 mg
2care4 - sakubitril / valsartan - tablett, filmdrasjert - 24 mg / 26 mg
entresto 49 mg / 51 mg
2care4 - sakubitril / valsartan - tablett, filmdrasjert - 49 mg / 51 mg
entresto 97 mg / 103 mg
2care4 - sakubitril / valsartan - tablett, filmdrasjert - 97 mg / 103 mg
aqumeldi
proveca pharma limited - enalapril (maleate) - hjertefeil - agenter som virker på renin-angiotensinsystemet - treatment of heart failure.
perindoprilarginin servier 5 mg
les laboratoires servier (4) - perindoprilarginin - tablett, filmdrasjert - 5 mg
triatec 5 mg
sanofi-aventis norge (3) - ramipril - tablett - 5 mg
triatec 2.5 mg
sanofi-aventis norge (3) - ramipril - tablett - 2.5 mg